These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12540339)

  • 41. Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.
    Topalovic M; Exadaktylos V; Decramer M; Berckmans D; Troosters T; Janssens W
    Respirology; 2015 Aug; 20(6):925-31. PubMed ID: 25880716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving adherence to alpha-1 antitrypsin deficiency screening guidelines using the pulmonary function laboratory.
    Luna Diaz LV; Iupe I; Zavala B; Balestrini KC; Guerrero A; Holt G; Calderon-Candelario R; Mirsaeidi M; Campos M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2257-2259. PubMed ID: 28814853
    [No Abstract]   [Full Text] [Related]  

  • 44. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
    Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
    Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strategies for screening for chronic obstructive pulmonary disease.
    Enright PL; Kaminsky DA
    Respir Care; 2003 Dec; 48(12):1194-201; discussion 1201-3. PubMed ID: 14651760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should we be using statistics to define disease?
    Mannino DM
    Thorax; 2008 Dec; 63(12):1031-2. PubMed ID: 19020267
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluating the extremely elderly at a pulmonary function clinic for the diagnosis of respiratory disease: frequency and technical quality of spirometry.
    Melo SMD; Oliveira LA; Wanderley JLF; Rocha RDA
    J Bras Pneumol; 2019 Jul; 45(4):e20180232. PubMed ID: 31365683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spirometry in chronic obstructive lung disease (COPD).
    Karkhanis VS; Joshi JM
    J Assoc Physicians India; 2012 Feb; 60 Suppl():22-6. PubMed ID: 23155809
    [No Abstract]   [Full Text] [Related]  

  • 49. It's time for an aetiology-based definition of chronic obstructive pulmonary disease.
    Miravitlles M; Morera J
    Respirology; 2007 May; 12(3):317-9. PubMed ID: 17539832
    [No Abstract]   [Full Text] [Related]  

  • 50. The diagnostic importance of a reduced FEV1/FEV6.
    Morris ZQ; Huda N; Burke RR
    COPD; 2012 Feb; 9(1):22-8. PubMed ID: 22292595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attaining a correct diagnosis of COPD in general practice.
    Bolton CE; Ionescu AA; Edwards PH; Faulkner TA; Edwards SM; Shale DJ
    Respir Med; 2005 Apr; 99(4):493-500. PubMed ID: 15763457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fixed ratio or lower limit of normal as cut-off value for FEV1/VC: an outcome study.
    Wollmer P; Engström G
    Respir Med; 2013 Sep; 107(9):1460-2. PubMed ID: 23845882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD).
    Schermer TR; Jacobs JE; Chavannes NH; Hartman J; Folgering HT; Bottema BJ; van Weel C
    Thorax; 2003 Oct; 58(10):861-6. PubMed ID: 14514938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status.
    Miravitlles M; Soriano JB; Ancochea J; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; García-Río F
    Respir Med; 2013 Jul; 107(7):1053-60. PubMed ID: 23597591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of a claims-based prediction model for COPD severity.
    Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
    Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lung function impairment, COPD hospitalisations and subsequent mortality.
    Garcia-Aymerich J; Serra Pons I; Mannino DM; Maas AK; Miller DP; Davis KJ
    Thorax; 2011 Jul; 66(7):585-90. PubMed ID: 21515553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Misdiagnosis Among Frequent Exacerbators of Clinically Diagnosed Asthma and COPD in Absence of Confirmation of Airflow Obstruction.
    Jain VV; Allison DR; Andrews S; Mejia J; Mills PK; Peterson MW
    Lung; 2015 Aug; 193(4):505-12. PubMed ID: 25921015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment.
    Allen S; Yeung P; Janczewski M; Siddique N
    Clin Respir J; 2008 Oct; 2(4):208-13. PubMed ID: 20298336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Return of GOLD 0?
    Figueira Gonçalves JM; García-Talavera I
    Arch Bronconeumol; 2017 Jan; 53(1):41. PubMed ID: 27646820
    [No Abstract]   [Full Text] [Related]  

  • 60. Quality of life measured by the St George's Respiratory Questionnaire and spirometry.
    Weatherall M; Marsh S; Shirtcliffe P; Williams M; Travers J; Beasley R
    Eur Respir J; 2009 May; 33(5):1025-30. PubMed ID: 19164350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.